Table 1

Patient characteristics and cardiovascular risk factors, stratified by sex and region

Total No.OverallEuropeAsiaMiddle East
MenWomenMenWomenMenWomenMenWomen
715429584851179911367461167413
Age (years)64.2 (11.2)67.5 (10.9)64.4 (10.8)68.3 (10.8) 66.3 (11.7) 67.7 (10.1) 61.6 (11.9) 63.5 (12.2)
Disease category
 CABG22.312.824.014.87.73.829.220.3
 PCI49.840.149.441.941.624.7 59.3 59.8
 SAP26.940.224.532.251.569.813.521.3
 ACS36.932.7 43.6 43.9 14.4 10.1 31.2 24.7
Family history of CHD31.133.3 42.7 43.3 24.632.5 4.4 4.0
Smoking status
 Current smoker18.79.518.814.424.72.713.71.2
 Ex-smoker47.517.652.826.642.05.234.12.0
 Never smoker32.872.128.559.033.392.152.29.7
Physical activity
 Adequate83.488.982.389.884.485.787.091.0
 Inadequate16.611.117.710.215.614.313.09.0
Known history
 Hypertension71.980.869.477.873.782.581.291.2
 Dyslipidaemia 67.8 67.1 68.6 68.8 43.952.1 89.0 88.8
 Diabetes31.940.324.227.234.848.171.686.7
  Type 1 1.9 2.5 1.3 2.1 0.3 0.4 13.4 20.5
  Type 230.538.5 23.0 25.3 34.647.769.284.5
Physical and laboratory measurements
 BMI (kg/m2) 28.0 (4.5) 28.2 (5.8) 28.0 (4.3) 28.5 (5.6) 25.1 (3.3) 25.4 (3.5)29.4 (5.4)32.8 (6.8)
 Waist circumference (cm)98.6 (14.4)92.8 (14.9)101.4 (14.2)95.9 (15.4)88.2 (9.0)84.3 (9.5) 100.2 (14.7) 100.3 (15.0)
 SBP (mmHg)130.5 (18.2)133.7 (19.3)131.5 (18.9)134.8 (20.4) 130.0 (16.2) 131.8 (16.6)127.0 (16.7)132.4 (18.1)
 DBP (mmHg) 76.2 (10.9) 76.0 (11.2) 77.0 (10.6) 77.0 (11.4) 77.2 (11.4) 76.7 (10.1) 71.8 (10.4) 70.5 (10.4)
 TC (mmol/L)4.2 (1.5)4.6 (1.5)4.3 (1.7)4.6 (1.8)4.2 (1.0)4.6 (1.0)3.8 (1.0)4.1 (0.9)
 LDL-C (mmol/L)2.4 (1.1)2.7 (1.2)2.4 (1.2)2.7 (1.3)2.6 (0.9)2.8 (0.9)2.1 (0.8)2.3 (0.7)
 HDL-C (mmol/L)1.1 (0.4)1.3 (0.5)1.1 (0.4)1.3 (0.5)1.1 (0.3)1.3 (0.4)0.9 (0.3)1.1 (0.3)
 Glucose (mmol/L)6.4 (2.5)6.7 (2.8)6.2 (2.2)6.4 (2.6) 6.2 (1.9) 6.5 (2.2)7.6 (3.6)8.8 (4.0)
 HbA1c (%) 7.3 (1.6) 7.4 (1.6) 7.2 (1.5) 7.5 (1.4) 6.8 (1.4) 6.8 (1.3) 7.8 (1.7) 8.3 (2.0)
Medications
 Antiplatelet91.786.392.289.586.176.595.189.8
 Antihypertensive 92.2 92.1 93.0 93.8 85.4 86.3 95.5 95.2
  β-blocker73.068.4 77.6 77.3 38.5 38.2 87.1 83.8
  CCB25.531.5 20.0 23.4 49.2 53.6 24.9 26.6
  ARB16.522.212.816.6 31.4 35.1 17.5 23.5
  ACE53.045.5 58.4 56.4 22.3 17.8 60.748.4
 Statin83.575.788.483.2 51.5 50.3 94.2 90.6
 Nitrate30.537.024.632.260.752.0 25.2 30.3
 Insulin8.712.46.08.2 5.7 8.0 22.838.3
 Oral hypoglycaemic agent21.225.4 14.5 15.8 24.7 33.1 45.8 53.3
  • Summary statistics are only performed for complete cases and missing values have been excluded. Results are shown as mean (SD) for continuous variables and percentage (number of observations/total number of non-missing data) for categorical variables.

  • Comparisons with p<0.1% are in italics.

  • ACE, angiotensin-converting enzyme; ACS, acute coronary syndrome; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass surgery; CCB, calcium channel blocker; CHD, coronary heart disease; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PCI, percutaneous coronary intervention; SAP, stable angina pectoris; SBP, systolic blood pressure; TC, total cholesterol.